Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease

: Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E, AAB-001 201/202 Investigators (incl. Scheinin M)

: 2012

Archives of Neurology -Chigago-

: 8

: 69

: 8

: 1002

: 1010

: 9

: 0003-9942